Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


23.04.2018

1 Am J Hematol
1 Ann Hematol
4 Blood
2 Bone Marrow Transplant
1 Br J Haematol
1 Cancer
1 Eur J Haematol
1 Exp Hematol
2 Genes Chromosomes Cancer
3 J Pediatr Hematol Oncol
2 J Virol
1 Leuk Lymphoma
2 Leuk Res
1 Oncol Rep
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. CUI L, Li ZG, Chai YH, Yu J, et al
    Outcome of children with newly diagnosed acute lymphoblastic leukemia treated with CCLG-ALL 2008: The first nation-wide prospective multicenter study in China.
    Am J Hematol. 2018 Apr 20. doi: 10.1002/ajh.25124.
    PubMed     Text format     Abstract available


    Ann Hematol

  2. BRECCIA M, Abruzzese E, Castagnetti F, Bonifacio M, et al
    Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice.
    Ann Hematol. 2018 Apr 19. pii: 10.1007/s00277-018-3337.
    PubMed     Text format     Abstract available


    Blood

  3. HASAN MK, Yu J, Widhopf GF 2nd, Rassenti LZ, et al
    Wnt5a induces ROR1 to recruit DOCK2 to activate Rac1/2 in chronic lymphocytic leukemia.
    Blood. 2018 Apr 20. pii: blood-2017-12-819383. doi: 10.1182/blood-2017-12-819383
    PubMed     Text format     Abstract available

  4. KLEINSTERN G, Camp NJ, Goldin LR, Vachon CM, et al
    Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.
    Blood. 2018 Apr 19. pii: blood-2017-11-814608. doi: 10.1182/blood-2017-11-814608
    PubMed     Text format     Abstract available

  5. PUENTE XS, Jares P, Campo E
    Chronic lymphocytic leukemia and mantle cell lymphoma: Crossroads of genetic and microenvironment interactions.
    Blood. 2018 Apr 17. pii: blood-2017-10-764373. doi: 10.1182/blood-2017-10-764373
    PubMed     Text format     Abstract available

  6. RANK CU, Toft N, Tuckuviene R, Grell K, et al
    Thromboembolism in Acute Lymphoblastic Leukemia: Results of NOPHO ALL2008 Protocol Treatment in Patients 1-45 Years.
    Blood. 2018 Apr 16. pii: blood-2018-01-827949. doi: 10.1182/blood-2018-01-827949
    PubMed     Text format     Abstract available


    Bone Marrow Transplant

  7. BATTIPAGLIA G, Ruggeri A, Labopin M, Volin L, et al
    Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemia.
    Bone Marrow Transplant. 2018 Apr 16. pii: 10.1038/s41409-018-0169.
    PubMed     Text format     Abstract available

  8. HALABURDA K, Labopin M, Houhou M, Niederwieser D, et al
    AlloHSCT for inv(3)(q21;q26)/t(3;3)(q21;q26) AML: a report from the acute leukemia working party of the European society for blood and marrow transplantation.
    Bone Marrow Transplant. 2018 Apr 18. pii: 10.1038/s41409-018-0165.
    PubMed     Text format     Abstract available


    Br J Haematol

  9. FRIDTHJOF KS, Kampmann P, Dunweber A, Gorlov JS, et al
    Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphoma.
    Br J Haematol. 2018 Apr 20. doi: 10.1111/bjh.15249.
    PubMed     Text format     Abstract available


    Cancer

  10. ASSI R, Kantarjian HM, Kadia TM, Pemmaraju N, et al
    Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.
    Cancer. 2018 Apr 16. doi: 10.1002/cncr.31398.
    PubMed     Text format     Abstract available


    Eur J Haematol

  11. OTA S, Matsukawa T, Yamamoto S, Shinichi I, et al
    Severe adverse events by tyrosine kinase inhibitors decrease survival rates in patients with newly diagnosed chronic phase chronic myeloid leukemia.
    Eur J Haematol. 2018 Apr 16. doi: 10.1111/ejh.13081.
    PubMed     Text format     Abstract available


    Exp Hematol

  12. NEWCOMBE AA, Gibson BES, Keeshan K
    Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia.
    Exp Hematol. 2018 Mar 30. pii: S0301-472X(18)30166.
    PubMed     Text format     Abstract available


    Genes Chromosomes Cancer

  13. TERADA K, Yamaguchi H, Ueki T, Usuki K, et al
    Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis.
    Genes Chromosomes Cancer. 2018 Apr 16. doi: 10.1002/gcc.22542.
    PubMed     Text format     Abstract available

  14. WANG X, Chen X, Yang Z, Dou H, et al
    Correlation of TET2 SNP rs2454206 with improved survival in children with acute myeloid leukemia featuring intermediate-risk cytogenetics.
    Genes Chromosomes Cancer. 2018 Apr 17. doi: 10.1002/gcc.22540.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  15. BOKLAN JL, Walsh AM, de la Maza MC, Su LL, et al
    Pediatric Chronic Myeloid Leukemia Presenting With Extreme Thrombocytosis Simulating Essential Thrombocythemia.
    J Pediatr Hematol Oncol. 2018 Apr 17. doi: 10.1097/MPH.0000000000001154.
    PubMed     Text format     Abstract available

  16. BECKTELL K, Houser K, Burke MJ
    Epigenetic Therapy in a Patient With Down Syndrome and Refractory Acute Myeloid Leukemia.
    J Pediatr Hematol Oncol. 2018 Apr 17. doi: 10.1097/MPH.0000000000001158.
    PubMed     Text format     Abstract available

  17. BOULANGER C, de Ville de Goyet M, de Magnee C, Dupont S, et al
    Multiple Epstein-Barr Virus-associated Smooth Muscle Sarcomas of the Gut in a Child Treated for Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2018 Apr 17. doi: 10.1097/MPH.0000000000001179.
    PubMed     Text format     Abstract available


    J Virol

  18. TEZUKA K, Okuma K, Kuramitsu M, Matsuoka S, et al
    Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available

  19. LI X, Chen W, Zhang H, Li A, et al
    Naturally Occurring Frameshift Mutations in the tvb Receptor Gene Are Responsible for Decreased Susceptibility of Chicken to Infection with Avian Leukosis Virus Subgroups B, D, and E.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  20. STAHL M, Pine A, Hendrickson JE, Litzow MR, et al
    Beliefs and practice patterns in hyperleukocytosis management in acute myeloid leukemia: a large U.S. web-based survey().
    Leuk Lymphoma. 2018 Apr 18:1-4. doi: 10.1080/10428194.2018.1452219.
    PubMed     Text format    


    Leuk Res

  21. HUANG J, Wang Z, Huang L, Zheng M, et al
    Corrigendum to 'CD41 immune staining of micromegakaryocytes improves the diagnosis of myelodysplastic syndrome and differentiation from pancytopenia' [leukemia research. 2018; 66: 15-19].
    Leuk Res. 2018;68:120.
    PubMed     Text format    

  22. TANG L, Wang N, Xing C, Zhuang Q, et al
    Effect of absolute monocyte count post-transplant on the outcome of patients with acute myeloid leukemia undergoing myeloablative allogeneic hematopoietic stem cell transplant with busulfan and cyclophosphamide conditioning.
    Leuk Res. 2018;69:60-65.
    PubMed     Text format     Abstract available


    Oncol Rep

  23. CHEN N, Feng L, Qu H, Lu K, et al
    Overexpression of IL-9 induced by STAT3 phosphorylation is mediated by miR-155 and miR-21 in chronic lymphocytic leukemia.
    Oncol Rep. 2018 Apr 12. doi: 10.3892/or.2018.6367.
    PubMed     Text format     Abstract available


    PLoS One

  24. PANAGOPOULOS I, Gorunova L, Jacobsen EM, Andersen K, et al
    RUNX1-PDCD6 fusion resulting from a novel t(5;21)(p15;q22) chromosome translocation in myelodysplastic syndrome secondary to chronic lymphocytic leukemia.
    PLoS One. 2018;13:e0196181.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: